Grace Li Smith, M.D., Ph.D., M.P.H.

Peer-Reviewed Articles

1. Hirata Y, To C, Lyu H, Smith GL, Samuel JP, Tran Cao HS, Badgwell BD, Katz MHG, Ikoma N. Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol 31(7):4361-4370, 2024. e-Pub 2024. PMID: 38536586.
2. Hirata Y, To C, Lyu H, Smith GL, Samuel JP, Cao HST, Badgwell BD, Katz MHG, Ikoma N. ASO Visual Abstract: Prevalence of and Factors Associated with Financial Toxicity After Pancreatectomy and Gastrectomy. Ann Surg Oncol 31(7):4396, 2024. e-Pub 2024. PMID: 38735902.
3. Shi C, De B, Tran Cao HS, Liu S, Florez MA, Kouzy R, Grippin AJ, Katz MHG, Tzeng CD, Ikoma N, Kim MP, Lee S, Willis J, Noticewala SS, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Ludmir EB, Koay EJ. Escalated-dose radiotherapy for unresected locally advanced pancreatic cancer: Patterns of care and survival in the United States. Cancer Med 13(12):e7434, 2024. PMID: 38923407.
4. Rooney MK, Niedzielski JS, Salazar RM, Arzola A, Das P, Koay EJ, Koong A, Ludmir EB, Minsky BD, Noticewala S, Smith GL, Taniguchi C, Holliday EB. Long-Term Patient-Reported Dyspareunia After Definitive Chemoradiation for Anal Cancer: Using the Anterior Vaginal Wall as an Organ-at-Risk to Define an Actionable Dosimetric Goal. Adv Radiat Oncol 9(5):101449, 2024. e-Pub 2024. PMID: 38550361.
5. Burus T, VanHelene AD, Rooney MK, Lang Kuhs KA, Christian WJ, McNair C, Mishra S, Paulino AC, Smith GL, Frank SJ, Warner JL. Travel-Time Disparities in Access to Proton Beam Therapy for Cancer Treatment. JAMA Netw Open 7(5):e2410670, 2024. e-Pub 2024. PMID: 38758559.
6. Chang E, Wong FCL, Chasen BA, Erwin WD, Das P, Holliday EB, Koong AC, Ludmir EB, Minsky BD, Noticewala SS, Smith GL, Taniguchi CM, Rodriguez MJ, Beddar S, Martin-Paulpeter RM, Niedzielski JS, Sawakuchi GO, Schueler E, Perles LA, Xiao L, Szklaruk J, Park PC, Dasari AN, Kaseb AO, Kee BK, Lee SS, Overman MJ, Willis JA, Wolff RA, Tzeng CD, Vauthey JN, Koay EJ. Phase I Trial of SPECT-Guided Liver-Directed Radiotherapy for Patients with Low Functional Liver Volume. JNCI Cancer Spectr. e-Pub 2024. PMID: 38730548.
7. Hirata Y, Lyu H, Smith GL, Wang XS, Tran Cao HS, Katz MHG, Ikoma N. What Defines the Value of Minimally Invasive Surgery for Cancer Patients?. Ann Surg Oncol 31(4):2204-2207, 2024. e-Pub 2023. PMID: 38123730.
8. Diao K, Lei X, He W, Jagsi R, Giordano SH, Smith GL, Caudle A, Shen Y, Peterson SK, Smith BD. Racial and Ethnic Differences in Long-Term Adverse Radiotherapy Effects among Breast Cancer Survivors. Int J Radiat Oncol Biol Phys 118(3):626-631, 2024. e-Pub 2023. PMID: 37751792.
9. Arzola A, Chang E, Rooney MK, Corrigan K, Das P, Ludmir EB, Koay EJ, Minsky BD, Smith GL, Messick C, Morris VK, Nebgen D, Crane CH, Holliday EB. Daily vaginal dilator use during radiation for women with squamous cell carcinoma of the anus: vaginal wall dosimetry and patient-reported sexual function. Pract Radiat Oncol 14(2):e105-e116, 2024. e-Pub 2023. PMID: 37898354.
10. Chen L, Wang C, Smith GL, Dawkins-Moultin L, Shin LJ, Lu Q. Job Loss and Well-Being Among Chinese American Breast Cancer Survivors: The Mediating Role of Income and Perceived Stress. Int J Behav Med. e-Pub 2024. PMID: 38169050.
11. Yanagihara TK, Tepper JE, Moon AM, Barry A, Molla M, Seong J, Torres F, Apisarnthanarax S, Buckstein M, Cardenes H, Chang DT, Feng M, Guha C, Hallemeier CL, Hawkins MA, Hoyer M, Iwata H, Jabbour SK, Kachnic L, Kharofa J, Kim TH, Kirichenko A, Koay EJ, Makishima H, Mases J, Meyer JJ, Munoz-Schuffenegger P, Owen D, Park HC, Saez J, Sanford NN, Scorsetti M, Smith GL, Wo JY, Yoon SM, Lawrence TS, Reig M, Dawson LA. Defining Minimum Treatment Parameters of Ablative Radiation Therapy in Patients With Hepatocellular Carcinoma: An Expert Consensus. Pract Radiat Oncol 14(2):134-145, 2024. e-Pub 2024. PMID: 38244026.
12. Diao K, Lei X, He W, Jagsi R, Giordano SH, Smith GL, Caudle A, Shen Y, Peterson SK, Smith BD. Patient-Reported Quality of Life after Breast Conserving Surgery with Radiotherapy versus Mastectomy and Reconstruction. Ann Surg 278(5):e1096-e1102, 2023. e-Pub 2023. PMID: 37232937.
13. Grover S, MacDuffie E, Nsingo M, Lei X, Mehta P, Davey S, Urusaro S, Chiyapo S, Vuylsteke P, Monare B, Bazzett-Matabele L, Ralefala T, Luckett R, Ramogola-Masire D, Smith GL. Benchmarking of the Cervical Cancer Care Cascade and Survival Outcomes After Radiation Treatment in a Low- and Middle-Income Country Setting. JCO Glob Oncol 9:e2200397, 2023. PMID: 37738538.
14. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Parsons SK, Roth M. Association of Patient-Reported Health-Related Quality of Life With Physician-Reported Toxicities in Adolescents and Young Adults Receiving Radiation Therapy for Cancer. JCO Oncol Pract 19(8):OP2200852, 2023. e-Pub 2023. PMID: 37311165.
15. De B, Upadhyay R, Liao K, Kumala T, Shi C, Dodoo G, Abi Jaoude J, Corrigan KL, Manzar GS, Marqueen KE, Bernard V, Lee SS, Raghav KPS, Vauthey JN, Tzeng CD, Tran Cao HS, Lee G, Wo JY, Hong TS, Crane CH, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Definitive Liver Radiotherapy for Intrahepatic Cholangiocarcinoma with Extrahepatic Metastases. Liver Cancer 12(3):198-208, 2023. e-Pub 2023. PMID: 37593365.
16. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Smith GL, Swartz MC, Lee KL, Afridi F, Andring LM, Bishop AJ, Gunther JR, Livingston JA, Peterson SK, Roth M. Patient-reported quality of life in adolescents and young adults with cancer who received radiation therapy. Cancer Med 12(13):14157-14170, 2023. e-Pub 2023. PMID: 37199075.
17. Rooney MK, De B, Corrigan K, Smith GL, Taniguchi C, Minsky BD, Ludmir EB, Koay EJ, Das P, Koong AC, Peacock O, Chang G, You YN, Morris VK, Nogueras-González G, Holliday EB. Patient-reported Bowel Function and Bowel-related Quality of Life After Pelvic Radiation for Rectal Adenocarcinoma: The Impact of Radiation Fractionation and Surgical Resection. Clin Colorectal Cancer 22(2):211-221, 2023. e-Pub 2023. PMID: 36878805.
18. Sapir E, Cherny NI, Ennis RD, Smith BD, Smith GL, Marks LB, Corn BW. Evaluation of the ESMO-Magnitude of Clinical Benefit Scale version 1.1 (ESMO-MCBS v1.1) for adjuvant radiotherapy in breast cancer. ESMO Open 8(3):101206, 2023. e-Pub 2023. PMID: 37236087.
19. Shi JJ, Lei X, Chen YS, Chavez-MacGregor M, Bloom E, Schlembach P, Shaitelman SF, Buchholz TA, Kaiser K, Ku K, Smith BD, Smith GL. Socioeconomic Barriers to Randomized Clinical Trial Retention in Patients Treated With Adjuvant Radiation for Early-Stage Breast Cancer. Int J Radiat Oncol Biol Phys 116(1):122-131, 2023. e-Pub 2023. PMID: 36724858.
20. Diao K, Lei X, Smith GL, Jagsi R, Peterson SE, Sumer BD, Smith BD, Sher DJ. Patient-Reported Financial Toxicity in a Population-Based Cohort of Oropharynx Cancer Survivors. Int J Radiat Oncol Biol Phys 116(1):142-153, 2023. e-Pub 2022. PMID: 36812043.
21. Dodoo GN, De B, Lee SS, Abi Jaoude J, Vauthey JN, Tzeng CD, Tran Cao HS, Katlowitz KA, Mandel JJ, Beckham TH, Minsky BD, Smith GL, Holliday EB, Koong AC, Das P, Taniguchi CM, Javle M, Koay EJ, Ludmir EB. Brain Metastases from Biliary Tract Cancer: Case Series and Clinicogenomic Analysis. Oncologist 28(4):327-332, 2023. e-Pub 2023. PMID: 36715178.
22. Gandhi A, Xu T, DeSnyder SM, Smith GL, Lin R, Barcenas CH, Stauder MC, Hoffman KE, Strom EA, Ferguson S, Smith BD, Woodward WA, Perkins GH, Mitchell MP, Garner D, Goodman CR, Aldrich M, Travis M, Lilly S, Bedrosian I, Shaitelman SF. Prospective, early longitudinal assessment of lymphedema-related quality of life among patients with locally advanced breast cancer: The foundation for building a patient-centered screening program. Breast 68:205-215, 2023. e-Pub 2023. PMID: 36863241.
23. Hernandez S, Das P, Holliday EB, Shen L, Lu W, Johnson B, Messick CA, Taniguchi CM, Skibber J, Ludmir EB, You YN, Smith GL, Bednarski B, Kostousov L, Koay EJ, Minsky BD, Tillman M, Portier S, Eng C, Koong AC, Chang GJ, Foo WC, Wang J, Soto LS, Morris VK. Differential Spatial Gene and Protein Expression Associated with Recurrence Following Chemoradiation for Localized Anal Squamous Cell Cancer. Cancers (Basel) 15(6), 2023. e-Pub 2023. PMID: 36980587.
24. Corrigan KL, Reeve BB, Salsman JM, Siembida EJ, Andring LM, Geng Y, Kouzy R, Livingston JA, Peterson SK, Bishop AJ, Smith GL, Gunther JR, Parsons SK, Roth M. Health-related quality of life in adolescents and young adults with cancer who received radiation therapy: a scoping review. Support Care Cancer 31(4):230, 2023. e-Pub 2023. PMID: 36961516.
25. De B, Maroongroge S, Smith GL. Letter to the editor regarding "disparities in telemedicine during COVID-19". Cancer Med 12(2):1556-1557, 2023. e-Pub 2022. PMID: 35837958.
26. Maroongroge S, De B, Woodhouse KD, Bassett RL, Lee P, Bloom ES, Smith GL, Frank SJ, Li J, Perkins G, Das P, Koong AC, Smith BD, Wang C. Physician Perspectives on Telemedicine in Radiation Oncology. Adv Radiat Oncol 8(2):101005, 2023. e-Pub 2022. PMID: 36311822.
27. Shi JJ, McGinnis GJ, Peterson SK, Taku N, Chen YS, Yu RK, Wu CF, Mendoza TR, Shete SS, Ma H, Volk RJ, Giordano SH, Shih YT, Nguyen DK, Kaiser KW, Smith GL. Pilot study of a Spanish language measure of financial toxicity in underserved Hispanic cancer patients with low English proficiency. Front Psychol 14:1188783, 2023. e-Pub 2023. PMID: 37492449.
28. Shi JJ, Maldonado JA, Wu CF, Peterson SK, Chen YS, Diao K, Volk RJ, Giordano SH, Shih YT, Kaiser K, Smith GL. Financial toxicity in cancer patients and subsequent risk of repeat acute care utilization. Front Psychol 14:1209526, 2023. e-Pub 2023. PMID: 37663351.
29. Koay EJ, Zaid M, Aliru M, Bagereka P, Van Wieren A, Rodriguez MJ, Jacobson G, Wolff RA, Overman M, Varadhachary G, Pant S, Wang H, Tzeng CW, Ikoma N, Kim M, Lee JE, Katz MH, Tamm E, Bhosale P, Taniguchi CM, Holliday EB, Smith GL, Ludmir EB, Minsky BD, Crane CH, Koong AC, Das P, Wang X, Javle M, Krishnan S. Nab-Paclitaxel, Capecitabine, and Radiation Therapy Following Induction Chemotherapy in Treating Patients with Locally Advanced and Borderline Resectable Pancreatic Cancer: Phase I Trial and Imaging-based Biomarker Validation. Int J Radiat Oncol Biol Phys 114(3):444-453, 2022. e-Pub 2022. PMID: 35863672.
30. Allen CJ, Smith GL, Prakash L, Volk RJ, Ikoma N, Aloia TA, Gottumukkala V, Katz MHG. What is "Value"? Results of a Survey of Cancer Patients and Providers. Ann Surg Oncol 29(11):6537-6545, 2022. e-Pub 2022. PMID: 35391609.
31. Khan Z, Rooney MK, Das P, Ludmir EB, Koay EJ, Smith GL, Taniguchi C, Minsky BD, Koong AC, Sawakuchi G, Beddar S, Martin RM, Rodriguez-Bigas M, Peacock O, Chang G, Holliday EB. Intraoperative Radiation After Pelvic Short Course Radiation-Based Total Neoadjuvant Therapy for Patients With Rectal Adenocarcinoma at High Risk for Local Recurrence. Clin Colorectal Cancer 21(3):204-211, 2022. e-Pub 2022. PMID: 35125321.
32. De B, Corrigan KL, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, You YN, Chang GJ, Westney OL, Nogueras Gonzalez GM, Holliday EB. Patient-reported bowel and urinary function in long-term survivors of squamous cell carcinoma of the anus treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys 114(1):78-88, 2022. e-Pub 2022. PMID: 35589011.
33. Smith GL, Banegas MP, Acquati C, Chang S, Chino F, Conti RM, Greenup RA, Kroll JL, Liang MI, Pisu M, Primm KM, Roth ME, Shankaran V, Yabroff KR. Navigating financial toxicity in patients with cancer: A multidisciplinary management approach. CA Cancer J Clin 72(5):437-453, 2022. e-Pub 2022. PMID: 35584404.
34. Wang CX, Elganainy D, Zaid MM, Butner JD, Agrawal A, Nizzero S, Minsky BD, Holliday EB, Taniguchi CM, Smith GL, Koong AC, Herman JM, Das P, Maitra A, Wang H, Wolff RA, Katz MHG, Crane CH, Cristini V, Koay EJ. Mass transport model of radiation response: calibration and application to chemoradiation for pancreatic cancer. Int J Radiat Oncol Biol Phys 114(1):163-172, 2022. e-Pub 2022. PMID: 35643254.
35. Corrigan KL, Rooney MK, De B, Ludmir ED, Das P, Smith GL, Taniguchi C, Minsky BD, Koay EJ, Koong A, Morris VK, Messick CA, Nogueras-Gonzalez G, Holliday EB. Patient-reported sexual function in long-term survivors of anal cancer treated with definitive intensity-modulated radiotherapy and concurrent chemotherapy. Pract Radiat Oncol 12(5):e397-e405, 2022. e-Pub 2022. PMID: 35643295.
36. Corrigan KL, Fu S, Chen YS, Kaiser K, Roth M, Peterson SK, Shih YT, Jagsi R, Giordano SH, Volk RJ, Yabroff KR, Banegas MP, Acquati C, Conti RM, Ma HY, Ku K, You YN, Smith GL. Financial toxicity impact on younger versus older adults with cancer in the setting of care delivery. Cancer 128(13):2455-2462, 2022. e-Pub 2022. PMID: 35417565.
37. De B, Tran Cao HS, Vauthey JN, Manzar GS, Corrigan KL, Raghav KPS, Lee SS, Tzeng CD, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Javle M, Ludmir EB, Koay EJ. Ablative liver radiotherapy for unresected intrahepatic cholangiocarcinoma: Patterns of care and survival in the United States. Cancer 128(13):2529-2539, 2022. e-Pub 2022. PMID: 35417569.
38. Moningi S, Lei X, Fang P, Taniguchi CM, Holliday EB, Koay EJ, Koong AC, Ludmir EB, Minsky BD, Das P, Giordano SH, Smith GL. Contemporary use and outcomes of radiation and chemotherapy for unresectable pancreatic cancer. Clin Transl Radiat Oncol 35:9-16, 2022. e-Pub 2022. PMID: 35510142.
39. Corrigan KL, De B, Rooney MK, Ludmir EB, Das P, Smith GL, Taniguchi CM, Minsky BD, Koay EJ, Koong AC, Holliday EB. Patient-Reported Outcomes After Chemoradiation in Patients With Anal Cancer: A Qualitative Analysis. Adv Radiat Oncol 7(4):100986, 2022. e-Pub 2022. PMID: 35662810.
40. Hanson SE, Lei X, Roubaud MS, DeSnyder SM, Caudle AS, Shaitelman SF, Hoffman KE, Smith GL, Jagsi R, Peterson SK, Smith BD. Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction. JAMA Surg 157(6):e220631, 2022. e-Pub 2022. PMID: 35416926.
41. De B, Fu S, Chen YS, Das P, Ku K, Maroongroge S, Woodhouse KD, Hoffman KE, Nguyen QN, Reed VK, Chen AB, Koong AC, Smith BD, Smith GL. Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care. Cancer Med 11(10):2096-2105, 2022. e-Pub 2022. PMID: 35297210.
42. McGinnis GJ, Ning MS, Beadle BM, Joubert N, Shaw W, Trauernich C, Simonds H, Grover S, Cardenas CE, Court LE, Smith GL. Barriers and Facilitators of Implementing Automated Radiotherapy Planning: A Multisite Survey of Low- and Middle-Income Country Radiation Oncology Providers. JCO Glob Oncol 8:e2100431, 2022. PMID: 35537104.
43. Manzar GS, De BS, Abana CO, Lee SS, Javle M, Kaseb AO, Vauthey JN, Tran Cao HS, Koong AC, Smith GL, Taniguchi CM, Holliday EB, Das P, Koay EJ, Ludmir EB. Outcomes and Toxicities of Modern Combined Modality Therapy with Atezolizumab Plus Bevacizumab and Radiation Therapy for Hepatocellular Carcinoma. Cancers (Basel) 14(8), 2022. e-Pub 2022. PMID: 35454808.
44. Allen CJ, Smith GL, Prakash L, Volk RJ, Ikoma N, Aloia TA, Gottumukkala V, Katz MHG. ASO Visual Abstract: What is "Value"? Results of a Survey of Cancer Patients and Providers. Ann Surg Oncol. e-Pub 2022. PMID: 35430655.
45. Taku N, Yi-Qian YN, Chang GJ, Ludmir EB, Raghav KPS, Rodriguez-Bigas MA, Holliday EB, Smith GL, Minsky BD, Overman MJ, Messick C, Boyce-Fappiano D, Koong AC, Skibber JM, Koay EJ, Dasari A, Taniguchi CM, Bednarski BK, Morris VK, Kopetz S, Das P. Benchmarking Outcomes for Definitive Treatment of Young-Onset, Locally Advanced Rectal Cancer. Clin Colorectal Cancer 21(1):e28-e37, 2022. e-Pub 2021. PMID: 34794903.
46. Holliday EB, Morris VK, Johnson B, Eng C, Ludmir EB, Das P, Minsky BD, Taniguchi C, Smith GL, Koay EJ, Koong AC, Delclos ME, Skibber JM, Rodriguez-Bigas MA, You YN, Bednarski BK, Tillman MM, Chang GJ, Jennings K, Messick CA. Definitive Intensity-Modulated Chemoradiation for Anal Squamous Cell Carcinoma: Outcomes and Toxicity of 428 Patients Treated at a Single Institution. Oncologist 27(1):40-47, 2022. PMID: 35305097.
47. Lin SH, Liao K, Lei X, Verma V, Shaaban S, Lee P, Chen AB, Koong AC, Hoftstetter WL, Frank SJ, Liao Z, Shih YT, Giordano SH, Smith GL. Health Care Resource Utilization for Esophageal Cancer Using Proton versus Photon Radiation Therapy. Int J Part Ther 9(1):18-27, 2022. e-Pub 2022. PMID: 35774487.
48. Xu C, Smith GL, Chen YS, Checka CM, Giordano SH, Kaiser K, Lowenstein LM, Ma H, Mendoza TR, Peterson SK, Shih YT, Shete S, Tang C, Volk RJ, Sidey-Gibbons C. Short-form adaptive measure of financial toxicity from the Economic Strain and Resilience in Cancer (ENRICh) study: Derivation using modern psychometric techniques. PLoS One 17(8):e0272804, 2022. e-Pub 2022. PMID: 36006909.
49. Maldonado JA, Fu S, Chen YS, Acquati C, Yabroff KR, Banegas MP, Chang S, Conti RM, Checka CM, Peterson SK, Advani P, Ku K, Jagsi R, Giordano SH, Volk RJ, Shih YT, Smith GL. Sensitivity of Psychosocial Distress Screening to Identify Cancer Patients at Risk for Financial Hardship During Care Delivery. JCO Oncol Pract 17(12):OP2001009, 2021. e-Pub 2021. PMID: 34043452.
50. Niedzielski JS, Liu Y, Ng SSW, Martin RM, Perles LA, Beddar S, Rebueno N, Koay EJ, Taniguchi C, Holliday EB, Das P, Smith GL, Minsky BD, Ludmir EB, Herman JM, Koong A, Sawakuchi GO. Dosimetric uncertainties resulting from interfractional anatomic variations for patients receiving pancreas stereotactic body radiation therapy and cone-beam CT image guidance. Int J Radiat Oncol Biol Phys 111(5):1298-1309, 2021. e-Pub 2021. PMID: 34400267.
51. De B, Abu-Gheida I, Patel A, Ng SSW, Zaid M, Thunshelle CP, Elganainy D, Corrigan KL, Rooney MK, Javle M, Raghav K, Lee SS, Vauthey JN, Tzeng CD, Tran Cao HS, Ludmir EB, Minsky BD, Smith GL, Holliday EB, Taniguchi CM, Koong AC, Das P, Koay EJ. Benchmarking Outcomes after Ablative Radiotherapy for Molecularly Characterized Intrahepatic Cholangiocarcinoma. J Pers Med 11(12), 2021. e-Pub 2021. PMID: 34945742.
52. Allen CJ, Pointer DT, Blumenthaler AN, Mehta RJ, Hoffe SE, Minsky BD, Smith GL, Blum M, Mansfield PF, Ikoma N, Das P, Ajani J, Dineen SP, Fleming JB, Badgwell BD, Pimiento JM. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Neoadjuvant Therapy for Resectable Gastric Adenocarcinoma: A Multi-Institutional Analysis. Ann Surg 274(4):544-548, 2021. e-Pub 2021. PMID: 34132693.
53. De B, Ludmir EB, Messick CA, Cagley MC, Morris VK, Das P, Minsky BD, Taniguchi CM, Smith GL, Koay EJ, Koong AC, Mohan R, Holliday EB. Prognostic impact of lymphopenia and neutrophil-lymphocyte ratio for patients with anal squamous cell carcinoma. J Gastrointest Oncol 12(5):2412-2422, 2021. PMID: 34790402.
54. Gharzai LA, Ryan KA, Szczygiel L, Goold S, Smith G, Hawley S, Pottow J, Jagsi R. Financial Toxicity During Breast Cancer Treatment: A Qualitative Analysis to Inform Strategies for Mitigation. JCO Oncol Pract 17(10):e1413-e1423, 2021. e-Pub 2021. PMID: 34251880.
55. Christopherson KM, Das P, Berlind C, Lindsay WD, Ahern C, Smith BD, Subbiah IM, Koay EJ, Koong AC, Holliday EB, Ludmir EB, Minsky BD, Taniguchi CM, Smith GL. A Machine Learning Model Approach to Risk-Stratify Gastrointestinal (GI) Cancer Patients for Hospitalization and Mortality Outcomes. Int J Radiat Oncol Biol Phys 111(1):135-142, 2021. e-Pub 2021. PMID: 33933480.
56. Smith GL, Mendoza TR, Lowenstein LM, Shih YT. Financial Hardship in Survivorship Care Delivery. J Natl Cancer Inst Monogr 2021(57):10-14, 2021. PMID: 34478512.
57. Tang C, Lei X, Smith GL, Pan HY, Hoffman KE, Kumar R, Chapin BF, Shih YT, Frank SJ, Smith BD. Influence of Geography on Prostate Cancer Treatment. Int J Radiat Oncol Biol Phys 109(5):1286-1295, 2021. e-Pub 2020. PMID: 33316361.
58. Moningi S, Abi Jaoude J, Kouzy R, Lin D, Nguyen ND, Garcia Garcia CJ, Phan JL, Avila S, Smani D, Cazacu IM, Singh BS, Smith GL, Holliday EB, Koay EJ, Das P, Bhutani MS, Herman JM, Minsky BD, Koong AC, Taniguchi CM. Impact of Fiducial Marker Placement Before Stereotactic Body Radiation Therapy on Clinical Outcomes in Patients With Pancreatic Cancer. Adv Radiat Oncol 6(2):100621, 2021. e-Pub 2020. PMID: 33912734.
59. Allen CJ, Blumenthaler AN, Smith GL, Das P, Minsky BD, Blum M, Ajani J, Mansfield PF, Ikoma N, Badgwell BD. Chemotherapy Versus Chemotherapy Plus Chemoradiation as Preoperative Therapy for Resectable Gastric Adenocarcinoma: A Propensity Score-Matched Analysis of a Large, Single-Institution Experience. Ann Surg Oncol 28(2):758-765, 2021. e-Pub 2020. PMID: 32696305.
60. De B, Ng SP, Liu AY, Avila S, Tao R, Holliday EB, Brownlee Z, Kaseb A, Lee S, Raghav K, Vauthey JN, Minsky BD, Herman JM, Das P, Smith GL, Taniguchi CM, Krishnan S, Crane CH, Grassberger C, Hong TS, Lin SH, Koong AC, Mohan R, Koay EJ. Radiation-Associated Lymphopenia and Outcomes of Patients with Unresectable Hepatocellular Carcinoma Treated with Radiotherapy. J Hepatocell Carcinoma 8:57-69, 2021. e-Pub 2021. PMID: 33688489.
61. Smith GL, Fu S, Ning MS, Nguyen DK, Busse PM, Foote RL, Garden AS, Gunn GB, Fuller CD, Morrison WH, Chronowski GM, Shah SJ, Mayo LL, Phan J, Reddy JP, Snider JW, Patel SH, Katz SR, Lin A, Mohammed N, Dagan R, Lee NY, Rosenthal DI, Frank SJ. Work Outcomes after Intensity-Modulated Proton Therapy (IMPT) versus Intensity-Modulated Photon Therapy (IMRT) for Oropharyngeal Cancer. Int J Part Ther 8(1):319-327, 2021. e-Pub 2021. PMID: 34285958.
62. Smith GL, Shih YT, Frank SJ. Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy. Int J Part Ther 8(1):366-373, 2021. e-Pub 2021. PMID: 34285962.
63. Abi Jaoude J, Kouzy R, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Pasalic D, Verma V, VanderWalde NA, Smith BD, Smith GL, Fuller CD, Das P, Minsky BD, Rödel C, Fokas E, Jagsi R, Thomas CR, Subbiah IM, Taniguchi CM, Ludmir EB. Performance Status Restriction in Phase III Cancer Clinical Trials. J Natl Compr Canc Netw 18(10):1322-1326, 2020. e-Pub 2020. PMID: 33022640.
64. Tang C, Lei X, Smith GL, Pan HY, Hess K, Chen A, Hoffman KE, Chapin BF, Kuban DA, Anscher M, Tina Shih YC, Frank SJ, Smith BD. Costs and Complications After a Diagnosis of Prostate Cancer Treated With Time-Efficient Modalities: An Analysis of National Medicare Data. Pract Radiat Oncol 10(4):282-292, 2020. e-Pub 2020. PMID: 32298794.
65. Zaky S, Cabrera AR, Bradfield L, Harkenrider MM, Kruser TJ, Sher DJ, Simone CB, Smith G, Petit J. The Evolution and Future of the American Society for Radiation Oncology (ASTRO) Clinical Practice Guidelines: A Report From the ASTRO Methodology Work Group on Behalf of the Guideline Subcommittee. Pract Radiat Oncol. e-Pub 2020. PMID: 32654976.
66. Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 19(2):116-122, 2020. e-Pub 2020. PMID: 32173279.
67. Lin SH, Hobbs BP, Verma V, Tidwell RS, Smith GL, Lei X, Corsini EM, Mok I, Wei X, Yao L, Wang X, Komaki RU, Chang JY, Chun SG, Jeter MD, Swisher SG, Ajani JA, Blum-Murphy M, Vaporciyan AA, Mehran RJ, Koong AC, Gandhi SJ, Hofstetter WL, Hong TS, Delaney TF, Liao Z, Mohan R. Randomized Phase IIB Trial of Proton Beam Therapy Versus Intensity-Modulated Radiation Therapy for Locally Advanced Esophageal Cancer. J Clin Oncol 38(14):JCO1902503, 2020. e-Pub 2020. PMID: 32160096.
68. Grant SR, Lei X, Hess KR, Smith GL, Matin SF, Wood CG, Nguyen Q, Frank SJ, Anscher MS, Smith BD, Karam JA, Tang C. Stereotactic Body Radiation Therapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison With Surgery, Tumor Ablation, and Observation. Adv Radiat Oncol 5(3):495-502, 2020. e-Pub 2020. PMID: 32529146.
69. Ludmir EB, Subbiah IM, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Mandel JJ, Fang P, Smith BD, Smith GL, Pinnix CC, Sedrak MS, Kimmick GG, Stinchcombe TE, Jagsi R, Thomas CR, Fuller CD, VanderWalde NA. Decreasing incidence of upper age restriction enrollment criteria among cancer clinical trials. J Geriatr Oncol 11(3):451-454, 2020. e-Pub 2019. PMID: 31711757.
70. Smith BD, Lei X, Diao K, Xu Y, Shen Y, Smith GL, Giordano SH, DeSnyder SM, Hunt KK, Teshome M, Jagsi R, Shaitelman SF, Peterson SK, Swanick CW. Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors. Ann Surg Oncol 27(4):1013-1022, 2020. e-Pub 2020. PMID: 31916092.
71. Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. JAMA Netw Open 3(3):e201255, 2020. e-Pub 2020. PMID: 32191331.
72. Ludmir EB, Fuller CD, Moningi S, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Verma V, Smith BD, Smith GL, VanderWalde NA, Holliday EB, Guadagnolo BA, Stinchcombe TE, Jagsi R, Gomez DR, Minsky BD, Rödel C, Fokas E. Sex-Based Disparities Among Cancer Clinical Trial Participants. J Natl Cancer Inst 112(2):211-213, 2020. e-Pub 2019. PMID: 31350545.
73. Moningi S, Ludmir EB, Polamraju P, Williamson T, Melkun MM, Herman JD, Krishnan S, Koay EJ, Koong AC, Minsky BD, Smith GL, Taniguchi C, Das P, Holliday EB. Definitive hyperfractionated, accelerated proton reirradiation for patients with pelvic malignancies. Clin Transl Radiat Oncol 19:59-65, 2019. e-Pub 2019. PMID: 31517071.
74. Smith GL, Lopez-Olivo MA, Advani PG, Ning MS, Geng Y, Giordano SH, Volk RJ. Financial Burdens of Cancer Treatment: A Systematic Review of Risk Factors and Outcomes. J Natl Compr Canc Netw 17(10):1184-1192, 2019. PMID: 31590147.
75. Hong YR, Smith GL, Xie Z, Mainous AG, Huo J. Financial burden of cancer care under the Affordable Care Act: Analysis of MEPS-Experiences with Cancer Survivorship 2011 and 2016. J Cancer Surviv 13(4):523-536, 2019. e-Pub 2019. PMID: 31183677.
76. Choi GW, Suh Y, Das P, Herman J, Holliday E, Koay E, Koong AC, Krishnan S, Minsky BD, Smith GL, Taniguchi CM, Beddar S. Assessment of setup uncertainty in hypofractionated liver radiation therapy with a breath-hold technique using automatic image registration-based image guidance. Radiat Oncol 14(1):154, 2019. e-Pub 2019. PMID: 31470860.
77. Christopherson K, Lei X, Barcenas C, Buchholz TA, Garg N, Hoffman KE, Kuerer HM, Mittendorf E, Perkins G, Shaitelman SF, Smith GL, Stauder M, Strom EA, Tereffe W, Woodward WA, Smith BD. Outcomes of Curative-Intent Treatment for Patients With Breast Cancer Presenting With Sternal or Mediastinal Involvement. Int J Radiat Oncol Biol Phys 104(3):574-581, 2019. e-Pub 2019. PMID: 30851348.
78. Advani PG, Lei X, Swanick CW, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Smith BD. Local Therapy Decisional Regret in Older Women With Breast Cancer: A Population-Based Study. Int J Radiat Oncol Biol Phys 104(2):383-391, 2019. e-Pub 2019. PMID: 30716524.
79. Ludmir EB, Mainwaring W, Lin TA, Miller AB, Jethanandani A, Espinoza AF, Mandel JJ, Lin SH, Smith BD, Smith GL, VanderWalde NA, Minsky BD, Koong AC, Stinchcombe TE, Jagsi R, Gomez DR, Thomas CR, Fuller CD. Factors Associated With Age Disparities Among Cancer Clinical Trial Participants. JAMA Oncol. e-Pub 2019. PMID: 31158272.
80. Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Yehia Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck 41(5):1546, 2019. e-Pub 2019. PMID: 30990235.
81. Fang P, Jagsi R, He W, Lei X, Campbell EG, Giordano SH, Smith GL. Rising and Falling Trends in the Use of Chemotherapy and Targeted Therapy Near the End of Life in Older Patients With Cancer. J Clin Oncol:JCO1802067. e-Pub 2019. PMID: 31141431.
82. Suidan RS, He W, Sun CC, Zhao H, Smith GL, Klopp AH, Fleming ND, Lu KH, Giordano SH, Meyer LA. National trends, outcomes, and costs of radiation therapy in the management of low- and high-intermediate risk endometrial cancer. Gynecol Oncol 152(3):439-444, 2019. PMID: 30876486.
83. An Y, Jiang W, Andraos TY, Reddy JP, Yehia ZA, Lloyd S, Duvic M, D'Souza NM, Milgrom SA, Pinnix CC, Oki Y, Smith GL, Wilson LD, Dabaja BS. Multi-institutional Investigation: Circulating CD4:CD8 ratio is a prognosticator of response to total skin electron beam radiation in mycosis fungoides. Radiother Oncol 131:88-92, 2019. e-Pub 2018. PMID: 30773193.
84. Milgrom SA, Elhalawani H, Lee J, Wang Q, Mohamed ASR, Dabaja BS, Pinnix CC, Gunther JR, Court L, Rao A, Fuller CD, Akhtari M, Aristophanous M, Mawlawi O, Chuang HH, Sulman EP, Lee HJ, Hagemeister FB, Oki Y, Fanale M, Smith GL. A PET Radiomics Model to Predict Refractory Mediastinal Hodgkin Lymphoma. Sci Rep 9(1):1322, 2019. e-Pub 2019. PMID: 30718585.
85. Elganainy D, Holliday EB, Taniguchi CM, Smith GL, Shroff R, Javle M, Raghav K, Kaseb A, Aloia TA, Vauthey JN, Tzeng CD, Herman JM, Koong AC, Krishnan SX, Minsky BD, Crane CH, Das P, Koay EJ. Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma. Cancer Med. e-Pub 2018. PMID: 30152073.
86. Hunt A, Das P, Minsky BD, Koay EJ, Krishnan S, Herman JM, Taniguchi C, Koong A, Smith GL, Holliday EB. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies. Radiat Oncol 13(1):143, 2018. e-Pub 2018. PMID: 30086784.
87. Pinnix CC, Huo J, Milgrom SA, Yehia ZA, Fanale M, Oki Y, Dabaja BS, Smith GL. Using benchmarked lung radiation dose constraints to predict pneumonitis risk: Developing a nomogram for patients with mediastinal lymphoma. Adv Radiat Oncol 3(3):372-381, 2018. e-Pub 2018. PMID: 30202805.
88. Fang P, He W, Gomez D, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL. Racial disparities in guideline-concordant cancer care and mortality in the United States. Adv Radiat Oncol 3(3):221-229, 2018. e-Pub 2018. PMID: 30202793.
89. Pinnix CC, Ng AK, Dabaja BS, Milgrom SA, Gunther JR, Fuller CD, Smith GL, Abou Yehia Z, Qiao W, Wogan CF, Akhtari M, Mawlawi O, Medeiros LJ, Chuang HH, Martin-Doyle W, Armand P, LaCasce AS, Oki Y, Fanale M, Westin J, Neelapu S, Nastoupil L. Positron emission tomography-computed tomography predictors of progression after DA-R-EPOCH for PMBCL. Blood Adv 2(11):1334-1343, 2018. PMID: 29895624.
90. Swanick CW, Lei X, Xu Y, Shen Y, Goodwin NA, Smith GL, Giordano SH, Hunt KK, Jagsi R, Shaitelman SF, Peterson SK, Smith BD. Long-term Patient-Reported Outcomes in Older Breast Cancer Survivors: A Population-Based Survey Study. Int J Radiat Oncol Biol Phys 100(4):882-890, 2018. e-Pub 2017. PMID: 29485067.
91. Reddy JP, Hernandez M, Gunther JR, Dabaja BS, Martin GV, Jiang W, Akhtari M, Allen PK, Atkinson BJ, Smith GL, Pinnix CC, Milgrom SA, Abou Yehia Z, Osborne EM, Oki Y, Lee H, Hagemeister F, Fanale MA. Pre-treatment neutrophil/lymphocyte ratio and platelet/lymphocyte ratio are prognostic of progression in early stage classical Hodgkin lymphoma. Br J Haematol 180(4):545-549, 2018. e-Pub 2017. PMID: 29271057.
92. Akhtari M, Milgrom SA, Pinnix CC, Reddy JP, Dong W, Smith GL, Mawlawi O, Abou Yehia Z, Gunther J, Osborne EM, Andraos TY, Wogan CF, Rohren E, Garg N, Chuang H, Khoury JD, Oki Y, Fanale M, Dabaja BS. Reclassifying patients with early-stage Hodgkin lymphoma based on functional radiographic markers at presentation. Blood 131(1):84-94, 2018. e-Pub 2017. PMID: 29038339.
93. Roberge D, Brown PD, Whitton A, O'Callaghan C, Leis A, Greenspoon J, Smith GL, Hu JJ, Nichol A, Winch C, Chan MD. The Future Is Now-Prospective Study of Radiosurgery for More Than 4 Brain Metastases to Start in 2018!. Front Oncol 8:380, 2018. e-Pub 2018. PMID: 30271753.
94. Ho JC, Dabaja BS, Milgrom SA, Smith GL, Reddy JP, Mazloom A, Young KH, Deng L, Medeiros LJ, Dong W, Allen PK, Andraos TY, Fowler NH, Nastoupil LJ, Oki Y, Fayad LE, Turturro F, Neelapu SS, Westin J, Hagemeister FB, Rodriguez MA, Pinnix CC. Radiation therapy improves survival in patients with testicular diffuse large B-cell lymphoma. Leuk Lymphoma 58(12):2833-2844, 2017. e-Pub 2017. PMID: 28482717.
95. Wang H, Milgrom SA, Dabaja BS, Smith GL, Martel M, Pinnix CC. Daily CT guidance improves target coverage during definitive radiation therapy for gastric MALT lymphoma. Pract Radiat Oncol s1879-8500(17):e471-e478, 2017. e-Pub 2017. PMID: 28377138.
96. Gunther JR, Rahman AR, Dong W, Yehia ZA, Kebriaei P, Rondon G, Pinnix Cc, Milgrom SA, Allen PD, Dabaja BS, Smith GL. Proton vs, Photon craniospinal irradiation for hematologic maliganicies involving the CNS: Effectiveness and toxicity in the setting of stem cell transplant, 2017.
97. Milgrom SA, Pinnix CC, Chuang H, Oki Y, Akhtari M, Mawlawi O, Garg N, Gunther JR, Reddy JP, Smith GL, Rohren E, Hagemeister FB, Lee HJ, Fayad LE, Dong W, Osborne EM, Abou Yehia Z, Fanale M, Dabaja BS. Early-stage Hodgkin lymphoma outcomes after combined modality therapy according to the post-chemotherapy 5-point score: can residual pet-positive disease be cured with radiotherapy alone?. Br J Haematol 179(3):488-496, 2017. e-Pub 2017. PMID: 28832956.
98. Gunther JR, Rahman AR, Dong W, Yehia ZA, Kebriaei P, Rondon G, Pinnix CC, Milgrom SA, Allen PK, Dabaja BS, Smith GL. Craniospinal irradiation prior to stem cell transplant for hematologic malignancies with CNS involvement: Effectiveness and toxicity after photon or proton treatment. Pract Radiat Oncol 7(6):e401-e408, 2017. e-Pub 2017. PMID: 28666906.
99. Jain P, Milgrom SA, Patel KP, Nastoupil L, Fayad L, Wang M, Pinnix CC, Dabaja BS, Smith GL, Yu J, Hu S, Bueso Ramos CE, Kanagal-Shamanna R, Medeiros LJ, Oki Y, Fowler N. Characteristics, management, and outcomes of patients with follicular dendritic cell sarcoma. Br J Haematol 178(3):403-412, 2017. e-Pub 2017. PMID: 28382648.
100. Swanick CW, Eifel PJ, Huo J, Meyer LA, Smith GL. Challenges to delivery and effectiveness of adjuvant radiation therapy in elderly patients with node-positive vulvar cancer. Gynecol Oncol 146(1):87-93, 2017. e-Pub 2017. PMID: 28506563.
101. Fang P, He W, Gomez DR, Hoffman KE, Smith BD, Giordano SH, Jagsi R, Smith GL. Influence of Age on Guideline-Concordant Cancer Care for Elderly Patients in the United States. Int J Radiat Oncol Biol Phys 98(4):748-757, 2017. e-Pub 2017. PMID: 28366580.
102. Smith GL, Duvic M, Yehia ZA, Allen P, Garg N, Suki T, Milgrom SA, Pinnix CC, Oki Y, Khoury JD, Dabaja BS. Effectiveness of low-dose radiation for primary cutaneous anaplastic large cell lymphoma. Adv Radiat Oncol 2(3):363-369, 2017. e-Pub 2017. PMID: 29114604.
103. Pinnix CC, Dabaja BS, Milgrom SA, Smith GL, Abou Z, Nastoupil L, Romaguera J, Turturro F, Fowler N, Fayad L, Westin J, Neelapu S, Fanale MA, Rodriguez MA, Hagemeister F, Lee HJ, Oki Y, Wang M, Samaniego F, Chi L, Esmaeli B. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck 39(6):1095-1100, 2017. e-Pub 2017. PMID: 28370694.
104. Milgrom SA, Jauhari S, Plastaras JP, Nieto Y, Dabaja BS, Pinnix CC, Smith GL, Allen PK, Lukens JN, Maity A, Oki Y, Fanale MA, Nasta SD. A multi-institutional analysis of peritransplantation radiotherapy in patients with relapsed/refractory Hodgkin lymphoma undergoing autologous stem cell transplantation. Cancer 123(8):1363-1371, 2017. e-Pub 2016. PMID: 27984652.
105. Smith GL, Ganz PA, Bekelman JE, Chmura SJ, Dignam JJ, Efstathiou JA, Jagsi R, Johnstone PA, Steinberg ML, Williams SB, Yu JB, Zietman AL, Weichselbaum RR, Tina Shih YC. Promoting the Appropriate Use of Advanced Radiation Technologies in Oncology: Summary of a National Cancer Policy Forum Workshop. Int J Radiat Oncol Biol Phys 97(3):450-461, 2017. e-Pub 2016. PMID: 28011046.
106. Milgrom SA, Dong W, Akhtari M, Smith GL, Pinnix CC, Mawlawi O, Rohren E, Garg N, Chuang H, Yehia ZA, Reddy JP, Gunther JR, Khoury JD, Suki T, Osborne EM, Oki Y, Fanale M, Dabaja BS. Chemotherapy Response Assessment by FDG-PET-CT in early-stage Classical Hodgkin Lymphoma: Moving Beyond the Five-Point Deauville Score. Int J Radiat Oncol Biol Phys 97(2):333-338, 2017. e-Pub 2016. PMID: 28068241.
107. Pinnix CC, Chi L, Jabbour EJ, Milgrom SA, Smith GL, Daver N, Garg N, Cykowski MD, Fuller G, Cachia D, Kamiya-Matsuoka C, Woodman K, Dinardo C, Jain N, Kadia TM, Pemmaraju N, Ohanian M, Konopleva M, Kantarjian HM, Dabaja BS. Dorsal column myelopathy after intrathecal chemotherapy for leukemia. Am J Hematol 92(2):155-160, 2017. PMID: 27874212.
108. Abou Yehia Z, Mikhaeel GN, Smith GL, Pinnix CC, Milgrom SA, Tang C, Jiang W, Fanale MA, Oki Y, Shank JH, Horace T, Reddy J, Akhtari M, Gunther JR, Suki T, Allen PK, Turner S, Mawlawi O, Dabaja BS. Does Bleomycin Lung Toxicity Increase the Risk of Radiation Pneumonitis in Hodgkin Lymphoma?. Int J Radiat Oncol Biol Phys 96(5):951-958, 2016.
109. Milgrom SA, Cheah CY, Pinnix CC, Smith GL, Dabaja BS, Horace P, Chevez-Barrios P, Fowler NH, Gombos DS. Acute and late toxicity of bilateral orbital irradiation in the management of primary intraocular lymphoma. Leuk Lymphoma 57(11):1-7, 2016. e-Pub 2016. PMID: 27075636.
110. Gunther JR, Fanale MA, Reddy JP, Akhtari M, Smith GL, Pinnix CC, Milgrom SA, Yehia ZA, Allen PK, Osborne EM, Mawlawi O, Dabaja BS. Treatment of Early-Stage Unfavorable Hodgkin Lymphoma: Efficacy and Toxicity of 4 Versus 6 Cycles of ABVD Chemotherapy With Radiation. Int J Radiat Oncol Biol Phys 96(1):110-118, 2016. e-Pub 2016. PMID: 27325479.
111. Pinnix CC, Osborne EM, Chihara D, Lai P, Zhou S, Ramirez MM, Oki Y, Hagemeister FB, Rodriguez AM, Samaniego F, Fowler N, Romaguera JE, Turturro F, Fayad L, Westin JR, Nastoupil L, Neelapu SS, Cheah CY, Dabaja BS, Milgrom SA, Smith GL, Horace P, Milbourne A, Wogan CF, Ballas L, Fanale MA. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy. JAMA Oncol 2(8):1065-1069, 2016. PMID: 27227654.
112. Milgrom SA, Nieto Y, Pinnix CC, Smith GL, Wogan CF, Rondon G, Medeiros LJ, Kebriaei P, Dabaja BS. Graft-versus-host disease after radiation therapy in patients who have undergone allogeneic stem cell transplantation: two case reports. J Med Case Rep 10(209):209, 2016. e-Pub 2016. PMID: 27465468.
113. Pinnix CC, Shah JJ, Chuang H, Costelloe CM, Medeiros LJ, Wogan CF, Reed V, Smith GL, Milgrom S, Patel K, Huo J, Turturro F, Romaguera J, Fayad L, Oki Y, Fanale MA, Westin J, Nastoupil L, Hagemeister FB, Rodriguez A, Qazilbash M, Shah N, Bashir Q, Ahmed S, Nieto Y, Hosing C, Rohren E, Dabaja B. Doxorubicin-Based Chemotherapy and Radiation Therapy Produces Favorable Outcomes in Limited-Stage Plasmablastic Lymphoma: A Single-Institution Review. Clin Lymphoma Myeloma Leuk 16(3):122-128, 2016. e-Pub 2015. PMID: 26795083.
114. Huo J, Giordano SH, Smith BD, Shaitelman SF, Smith GL. Contemporary Toxicity Profile of Breast Brachytherapy Versus External Beam Radiation After Lumpectomy for Breast Cancer. Int J Radiat Oncol Biol Phys 94(4):709-718, 2016. e-Pub 2015. PMID: 26972643.
115. Akhtari M, Reddy JP, Pinnix CC, Allen PK, Osborne EM, Gunther JR, Milgrom SA, Smith GL, Wogan CF, Fowler N, Rodriguez MA, Dabaja B. Primary cutaneous B-cell lymphoma (non-leg type) has excellent outcomes even after very low dose radiation as single-modality therapy. Leuk Lymphoma 57(1):34-38, 2016. e-Pub 2015. PMID: 25860237.
116. Reddy JP, Akhtari M, Smith GL, Pinnix C, Osborne EM, Gunther JR, Allen PK, Yehia ZA, Fanale M, Rodriguez MA, Fowler N, Milgrom SA, Wogan CF, Dabaja BS. Outcomes After Chemotherapy Followed by Radiation for Stage IIB Hodgkin Lymphoma With Bulky Disease. Clin Lymphoma Myeloma Leuk 15(11):664-670.e2, 2015. e-Pub 2015. PMID: 26321471.
117. Smith GL, Huo J, Giordano SH, Hunt KK, Buchholz TA, Smith BD. Utilization and Outcomes of Breast Brachytherapy in Younger Women. Int J Radiat Oncol Biol Phys 93(1):91-101, 2015. e-Pub 2015. PMID: 26279027.
118. Youssef B, Shank J, Reddy JP, Pinnix CC, Farha G, Akhtari M, Allen PK, Fanale MA, Garcia JA, Horace PH, Milgrom S, Smith GL, Nieto Y, Arzu I, Wang H, Fowler N, Rodriguez MA, Dabaja B. Incidence and predictors of Lhermitte's sign among patients receiving mediastinal radiation for lymphoma. Radiat Oncol 10:206, 2015. e-Pub 2015. PMID: 26407853.
119. Smith GL, Jiang J, Giordano SH, Meyer LA, Eifel PJ. Trends in the quality of treatment for patients with intact cervical cancer in the United States, 1999 through 2011. Int J Radiat Oncol Biol Phys 92(2):260-267, 2015. PMID: 25968823.
120. Pinnix CC, Smith GL, Milgrom S, Osborne EM, Reddy JP, Akhtari M, Reed V, Arzu I, Allen PK, Wogan CF, Fanale MA, Oki Y, Turturro F, Romaguera J, Fayad L, Fowler N, Westin J, Nastoupil L, Hagemeister FB, Rodriguez MA, Ahmed S, Nieto Y, Dabaja B. Predictors of radiation pneumonitis in patients receiving intensity modulated radiation therapy for Hodgkin and non-Hodgkin lymphoma. Int J Radiat Oncol Biol Phys 92(1):175-182, 2015. PMID: 25863764.
121. Hoffman KE, Niu J, Shen Y, Jiang J, Davis JW, Kim J, Kuban DA, Perkins GH, Shah JB, Smith GL, Volk RJ, Buchholz TA, Giordano SH, Smith BD. Physician variation in management of low-risk prostate cancer: a population-based cohort study. JAMA Intern Med 174(9):1450-1459, 2014. PMID: 25023650.
122. Smith GL, Smith BD. Radiation Treatment in Older Patients: A framework for clinical decision making. J Clin Oncol 32(24):2669-2678, 2014. e-Pub 2014. PMID: 25071132.
123. Eberth JM, Xu Y, Smith GL, Shen Y, Jiang J, Buchholz TA, Hunt KK, Black DM, Giordano SH, Whitman GJ, Yang W, Shen C, Elting L, Smith BD. Surgeon influence on use of needle biopsy in patients with breast cancer: a national medicare study. J Clin Oncol 32(21):2206-2216, 2014. e-Pub 2014. PMID: 24912900.
124. Smith GL, Jiang J, Buchholz TA, Xu Y, Hoffman KE, Giordano SH, Hunt KK, Smith BD. Benefit of adjuvant brachytherapy versus external beam radiation for early breast cancer: impact of patient stratification on breast preservation. Int J Radiat Oncol Biol Phys 88(2):274-284, 2014. e-Pub 2013. PMID: 24268788.
125. Smith BD, Smith GL, Buchholz TA. Brachytherapy vs whole-breast irradiation: trial by data. Int J Radiat Oncol Biol Phys 83(4):1078-1080, 2012. PMID: 22704702.
126. Smith GL, Xu Y, Buchholz TA, Giordano SH, Jiang J, Shih YC, Smith BD. Association between treatment with brachytherapy vs whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA 307(17):1827-1837, 2012. PMID: 22550197.
127. Smith BD, Jiang J, McLaughlin SS, Hurria A, Smith GL, Giordano SH, Buchholz TA. Improvement in Breast Cancer Outcomes Over Time: Are Older Women Missing Out?. J Clin Oncol 29(35):4647-4653, 2011. e-Pub 2011. PMID: 22067407.
128. Shih YC, Chien CR, Xu Y, Pan IW, Smith GL, Buchholz TA. Economic burden of renal cell carcinoma in the US: Part I- an updated review. Pharmacoeconomics 29(4):315-329, 2011. PMID: 21395351.
129. Shih YC, Chien CR, Xu Y, Pan IW, Smith GL, Buchholz TA. Economic burden of renal cell carcinoma in the US: Part II--an updated analysis. Pharmacoeconomics 29(4):331-341, 2011. PMID: 21395352.
130. Smith GL, Shih YT, Xu Y, Giordano SH, Smith BD, Buchholz TA. Breast brachytherapy in the United States: How is the emerging modality being incorporated into the care of older breast cancer patients?. J Clin Oncol 29(2):157-165, 2011.
131. Smith BD, Haffty BG, Wilson LD, Smith GL, Patel AN, Buchholz TA. The Future of Radiation Oncology in the United States from 2010 to 2020: Will supply keep pace with demand?. J Clin Oncol 28(35):5160-5166, 2010. e-Pub 2010. PMID: 20956628.
132. Walker GV, Smith GL, Perkins GH, Oh JL, Woodward W, Yu TK, Hunt KK, Hoffman K, Strom EA, Buchholz TA. Population-based analysis of occult primary breast cancer with axillary lymph node metastasis. Cancer 116(17):4000-4006, 2010. PMID: 20564117.
133. Smith GL, Shih YC, Xu Y, Giordano SH, Smith BD, Perkins GH, Tereffe W, Woodward WA, Buchholz TA. Racial disparities in treatment for early invasive breast cancer: a national Medicare study of radiotherapy after conservative surgery. Cancer 116(3):734-741, 2010. PMID: 20014181.
134. Smith GL, Shih YC, Giordano SH, Smith BD, Buchholz TA. A method to predict breast cancer stage using Medicare claims. Epidemiol Perspect Innov 7(1):1, 2010. e-Pub 2010. PMID: 20145734.
135. Smith GL, Xu Y, Shih YC, Giordano SH, Smith BD, Hunt KK, Strom EA, Perkins GH, Hortobagyi GN, Buchholz TA. Breast-conserving surgery in older patients with invasive breast cancer: current patterns of treatment across the United States. J Am Coll Surg 209(4):425-433.e2, 2009. e-Pub 2009. PMID: 19801315.
136. Smith BD, Smith GL, Roberts KB, Buchholz TA. Baseline utilization of breast radiotherapy prior to institution of the Medicare Practice Quality Reporting Initiative. Int J Radiat Oncol Biol Phys 74(5):1506-1512, 2009. e-Pub 2009. PMID: 19395182.
137. Smith GL, Smith BD, Garden AS, Rosenthal DI, Sherman SI, Morrison WH, Schwartz DL, Weber RS, Buchholz TA. Hypothyroidism in older head and neck cancer patients after treatment with radiation: A population-based study. Head Neck 31(8):1031-1038, 2009. PMID: 19360741.
138. Smith GL, Smith BD, Buchholz TA, Liao Z, Jeter M, Swisher SG, Hofstetter WL, Ajani JA, McAleer MF, Komaki R, Cox JD. Patterns of care and local-regional treatment outcomes in older esophageal cancer patients. Int J Radiat Oncol Biol Phys 74(2):482-489, 2009. e-Pub 2009. PMID: 19289262.
139. Smith BD, Smith GL, Hurria A, Hortobagyi GN, Buchholz TA. The future of cancer incidence in the United States: Expected burdens upon an aging, changing nation. J Clin Oncol 27(17):2758-2765, 2009. e-Pub 2009. PMID: 19403886.
140. Smith GL, Smith BD, Buchholz TA, Giordano SH, Garden AS, Woodward WA, Krumholz HM, Weber RS, Ang KK, Rosenthal DI. Cerebrovascular disease risk in older head and neck cancer patients treated with radiation therapy. J Clin Oncol 23(31):5119-5125, 2008. e-Pub 2008. PMID: 18725647.
141. Smith BD, Haffty BG, Smith GL, Hurria A, Buchholz TA, Gross CP. Use of postmastectomy radiotherapy in older women. Int J Radiat Oncol Biol Phys 71(1):98-106, 2008. e-Pub 2007. PMID: 17996393.
142. Smith GL, Smith BD, Giordano SH, Shih YC, Woodward WA, Strom EA, Perkins GH, Tereffe W, Yu TK, Buchholz TA. Risk of hypothyroidism in older breast cancer patients treated with radiation. Cancer 112(6):1371-1379, 2008. PMID: 18213620.
143. Austin BA, Wang Y, Smith GL, Vaccarine V, Krumholz HM, McNamara RL. Systolic function as a predictor of mortality and quality of life in long-term survivors with heart failure. Clin Cardiol 31(3):119-124, 2008. PMID: 18383045.
144. Smith GL, Masoudi FA, Shlipak MG, Krumholz HM, Parikh CR. Renal impairment predicts long-term mortality risk after acute myocardial infarction. J Am Soc Nephrol 19(1):141-50, 2008. e-Pub 2007. PMID: 18003773.
145. Smith GL, Masoudi FA, Shlipak MG, Krumholz HM, Parikh CR. Renal function predicts up to 10-year mortality risks after acute myocardial infarction (AMI) in elderly patients. J AM Soc Nephrol 19:141-150, 2008.
146. Brosius FC, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, Pennathur S, Smith GL, Wilson PW, American Heart Association Kidney and Cardiovascular Disease Council, Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention, Quality of Care and Outcomes Research Interdisciplinary Working Group, National Kidney Foundation. Detection of chronic kidney disease in patients with or at increased. Hypertension 48(4):751-755, 2006. PMID: 16990648.
147. Parikh CR, Coca SG, Smith GL, Vaccarino V, Krumholz HM. Impact of chronic kidney disease on health-related quality-of-life improvement after coronary artery bypass surgery. Arch Intern Med 166(18):2014-2019, 2006. PMID: 17030836.
148. Smith BD, Haffty BG, Buchholz TA, Smith GL, Galusha DH, Bekelman JE, Gross CP. Effectiveness of radiation therapy in older women with ductal carcinoma in situ. J Natl Cancer Inst 98(18):1302-1310, 2006. PMID: 16985249.
149. Brosius FC, Hostetter TH, Kelepouris E, Mitsnefes MM, Moe SM, Moore MA, Pennathur S, Smith GL, Wilson PW, American Heart Association Kidney and Cardiovascular Disease Council, Council on High Blood Pressure Research, Council on Cardiovascular Disease in the Young, Council on Epidemiology and Prevention, Quality of Care and Outcomes Research Interdisciplinary Working Group. Detection of chronic kidney disease in patients with or at increased risk of cardiovascular disease: a science advisory from the American Heart Association Kidney And Cardiovascular Disease Council; the Councils on High Blood Pressure Research, Cardiovascular Disease in the Young, and Epidemiology and Prevention; and the Quality of Care and Outcomes Research Interdisciplinary Working Group: developed in collaboration with the National Kidney Foundation. Circulation 114(10):1083-1087, 2006. e-Pub 2006. PMID: 16894032.
150. Smith GL, Smith BD, Haffty BG. Rationalization and regionalization of treatment for ductal carcinoma in situ of the breast. Int J Radiat Oncol Biol Phys 65(5):1397-403, 2006. e-Pub 2006. PMID: 16750316.
151. Smith GL, Lichtman JH, Bracken MB, Shlipak MG, Phillips CO, DiCapua P, Krumholz HM. Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol 47(10):1987-1996, 2006. e-Pub 2006. PMID: 16697315.
152. Smith BD, Gross CP, Smith GL, Galusha DH, Bekelman JE, Haffty BG. Effectiveness of radiation therapy for older women with early breast cancer. J Natl Cancer Inst 98(10):681-690, 2006. PMID: 16705122.
153. Smith GL, Shlipak MG, Havranek EP, Foody JM, Masoudi FA, Rathore SS, Krumholz HM. Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease. Arch Intern Med 166(10):1134-1142, 2006. PMID: 16717177.
154. Kosiborod M, Curtis JP, Wang Y, Smith GL, Masoudi FA, Foody JM, Havranek EP, Krumholz HM. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project. Arch Intern Med 165(19):2237-2244, 2005. PMID: 16246989.
155. Cheng S, Lichtman JH, Amatruda JM, Smith GL, Mattera JA, Roumanis SA, Krumholz HM. Knowledge of blood pressure levels and targets in patients with coronary artery disease in the USA. J Hum Hypertens 19(10):769-774, 2005. PMID: 16049521.
156. Smith BD, Smith GL, Cooper DL, Wilson LD. The cutaneous B-cell lymphoma prognostic index: a novel prognostic index derived from a population-based registry. J Clin Oncol 23(15):3390-3395, 2005.
157. Smith GL, Shlipak MG, Havranek EP, Masoudi FA, McClellan WM, Foody JM, Rathore SS, Krumholz HM. Race and renal impairment in heart failure: mortality in blacks versus whites. Circulation 111(10):1270-1277, 2005. PMID: 15769768.
158. Smith BD, Smith GL, Haffty BG. Postmastectomy radiation and mortality in women with T1-2 node-positive breast cancer. J Clin Oncol 23(7):1409-19, 2005. PMID: 15735117.
159. Cheng S, Lichtman JH, Amatruda JM, Smith GL, Mattera JA, Roumanis SA, Krumholz HM. Knowledge of cholesterol levels and targets in patients with coronary artery disease. Prev Cardiol 8(1):11-17, 2005. PMID: 15722689.
160. Shlipak MG, Smith GL, Rathore SS, Massie BM, Krumholz HM. Renal function, digoxin therapy, and heart failure outcomes: evidence from the digoxin intervention group trial. J Am Soc Nephrol 15(8):2195-203, 2004. PMID: 15284305.
161. Lichtman JH, Amatruda J, Yaari S, Cheng S, Smith GL, Mattera JA, Roumanis SA, Wang Y, Radford MJ, Krumholz HM. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. Am Heart J 147(3):522-8, 2004. PMID: 14999204.
162. Smith BD, Glusac EJ, McNiff JM, Smith GL, Heald PW, Cooper DL, Wilson LD. Primary cutaneous B-cell lymphoma treated with radiotherapy; a comparison of the European Organization for Research and Treatment of Cancer and the WHO classification system. J Clin Oncol 22(4):634-639, 2004. PMID: 14966086.
163. Smith GL, Masoudi FA, Vaccarino V, Radford MJ, Krumholz HM. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41(9):1510-1518, 2003. PMID: 12742291.
164. Rathore SS, Foody JM, Wang Y, Smith GL, Herrin J, Masoudi FA, Wolfe P, Havranek EP, Ordin DL, Krumholz HM. Race, quality of care, and outcomes of elderly patients hospitalized with heart failure. JAMA 289(19):2517-2524, 2003. PMID: 12759323.
165. Kosiborod M, Smith GL, Radford MJ, Foody JM, Krumholz HM. The prognostic importance of anemia in patients with heart failure. Am J Med 114(2):112-119, 2003. PMID: 12586230.
166. Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM. Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure?. J Card Fail 9(1):13-25, 2003. PMID: 12612868.
167. Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA, Radford MJ, Crombie P, Vaccarino V. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 39(1):83-89, 2002. PMID: 11755291.
168. Havranek EP, Masoudi FA, Smith GL, Wolfe P, Ralston DL, Krumholz HM, Ordin DL. Lessons learned from the national heart failure project: a Center for Medicare and Medicaid services initiative to improve the care of Medicare beneficiaries with heart failure. Congest Heart Fail 7(6):334-336, 2001. PMID: 11828183.
169. Wexler DJ, Chen J, Smith GL, Radford MJ, Yaari S, Bradford WD, Krumholz HM. Predictors of costs of caring for elderly patients discharged with heart failure. Am Heart J 142(2):350-357, 2001. PMID: 11479477.
170. Smith BD, Smith GL, Carter D, DiGiovanna MP, Kasowitz KM, Sasaki CT, Haffty BG. Molecular marker expression in oral and oropharyngeal squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 127(7):780-785, 2001. PMID: 11448349.
171. Smith BD, Smith GL, Carter D, Sasaki CT, Haffty BG. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 18(10):2046-2052, 2000. PMID: 10811669.

Invited Articles

1. Milgrom SA, Smith GL, Pinnix CC. Commentary on: Breast cancer risk following Hodgkin lymphoma radiotherapy in relation to menstrual and reproductive factors. Br J Cancer 108:2399-2406, 2013. Breast Diseases Quarterly 26(3):253-254, 2015.
2. Smith GL. Commentary on: Characteristics Associated With Differences in Survival Among Black and White Women with Breast Cancer. JAMA 310:389-397, 2013. Breast Diseases Quarterly 25(1):35-36, 2014.
3. Smith GL. Commentary on: Do radiation use disparities influence survival in patients with advanced breast cancer? Cancer 118:196-204, 2012. Breast Diseases Quarterly 23(2):184, 2012.
4. Smith GL. Commentary on: Race and ethnicity and breast cancer outcomes in an underinsured population. J Natl Cancer Inst 102:1178-1187, 2010. Breast Diseases Quarterly 22(2):131, 2011.
5. Smith GL, Buchholz TA. Commentary on: Correlates and effect of suboptimal radiotherapy in women with ductal carcinoma in situ or early invasive breast cancer. Cancer 113:3108-3115, 2008. Breast Diseases Quarterly 20(2):204-205, 2009.
6. Smith GL. Commentary on: Completion of adjuvant radiation therapy among women with breast cancer. Cancer 113:22-29, 2008. Breast Diseases Quarterly 20(3):307-308, 2009.
7. Smith GL. Commentary on: Population-based study of trends and variations in radiotherapy as part of primary treatment of cancer in the southern Netherlands between 1988 and 2006, with an emphasis on breast and rectal cancer. Int J Radiat Oncol Biol Phys 74:464-471, 2009. Breast Diseases Quarterly 20(4):439-440, 2009.
8. Smith GL, Buchholz TA. Commentary on: Radiotherapy following breast-conserving surgery for screen-detected ductal carcinoma in situ: indications and utilisation in the UK. Interim findings from the Sloane Project. Br J Cancer 97:725-729, 2007. Breast Diseases Quarterly: July-September 19(2):168, 2008.
9. Smith BD, Smith GL, Buchholz TA.. Controversies over the role of radiation therapy for ductal carcinoma in situation. Expert Rev Anticancer Ther 8(3):433-341, 2008.
10. Smith GL, Buchholz TA.. Commentary on: The use of radiation therapy after breast- conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty. Am J Surg 195:793-798, 2008.
11. Smith GL. Commentary: Disparities in Breast Cancer Treatment and Survival for Women with Disabilities. Ann Intern Med 145:637-645, 2006. Breast Diseases Quarterly: July-September 18(2):211-212, 2007.

Editorials

1. Smith GL, Smith BD. Sea Change: A Decade of Intensity-Modulated Radiation Therapy for Treatment of Breast Cancer. J Natl Cancer Inst 112(3):221-3, 2020. PMID: 31647554.
2. Romesser PB, Smith GL, Crane CH. Non-Operative Management of Rectal Cancer Shows Cost-Effectiveness, but Can Comparative Effectiveness Be Established. J Natl Cancer Inst, 2020.
3. Kaleem T, Smith GL, Miller RC. Impact of care disparities in radiation oncology. Adv Radiat Oncol 20(3):1-2, Jan-Mar, 2018. PMID: 29556571.
4. Smith GL. Perspectives on Postmastectomy Radiation Therapy for Persistent Nodal Disease After Neoadjuvant Chemotherapy: Is Hindsight 20/20?. Int J Radiat Oncol Biol Phys 1(99):560-2, 2017.
5. Smith GL. Toward Minimizing Overtreatment and Undertreatment of Ductal Carcinoma In Situ in the United States. J Clin Oncol 34(11):1172-1174, 2016.
6. Schipper M, Taylor J, Smith GL, Jagsi R. Comparing long-term treatment-associated toxicities in cancer patients: Approaches, caveats, and recommendations. Int J Radiat Oncol Biol Phys 89(2):232-234, 2014. PMID: 24837886.

Book Chapters

1. Smith GL, Dabaja BS. Mycosis Fungoides. In: Radiation Therapy in Hematologic Malignancies. 1st Ed. Springer: New York, 2016.
2. Smith GL, Wilson LD, Dabaja BS, Gunderson LL, Tepper Je.. Chapter 77. Mycosis Fungoides. In: Clinical Radiation Oncology. 3rd. Ed(s) Gunderson LL, Tepper JE. Elsevier Churchill Livingston: Philadelphia, PA, 2014.

Letters to the Editor

1. Smith GL, Das P, Herman JM, Koay EJ, Koong AC, Grossberg A, Ludmir E. . Comparing ablative modalities for hepatocellular carcinoma: Cautions in interpreting big data. J Clin Oncol 36: 2565-2566, 2018.
2. Smith GL, Volk RJ. Nonclinical Factors Affecting Shared Decision Making. JAMA 318: 391, 2017.
3. Smith GL. Reply to K. Lin et al. J Clin Oncol 34: 3486, 2016.
4. Smith GL, Eifel PJ. In regard to Han et al. Int J Radiat Oncol Biol Phys 88: 459-460, 2014.
5. Smith GL, Buchholz TA, Smith BD. In reply to Khan et al. JAMA 308: 567-568, 2012.